Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#131 / 189 Total
ERAS - Erasca Inc - Stock Price Chart
TickerERAS [NASD, RUT]
CompanyErasca Inc
CountryUSA
IndustryBiotechnology
Market Cap341.52MEPS (ttm)-0.84
P/E-EPS this Y-3.53%
Forward P/E-EPS next Y-4.57%
PEG-EPS past 5Y-69.36%
P/S-EPS next 5Y-
P/B1.03EPS Q/Q-4.28%
Dividend-Sales Q/Q-
Insider Own40.58%Inst Own34.52%
Insider Trans1.50%Inst Trans2.79%
Short Float10.20%EarningsMay 08/a
Analyst Recom1.33Target Price6.62
Avg Volume779.94K52W Range1.51 - 3.38
Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim on July 1, 2018 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lim Jonathan EChairman & CEODec 06 '23Buy1.72278,150478,41812,899,360Dec 06 07:41 PM
Start Valerie Denise HardingDirectorDec 06 '23Buy1.8510,00018,48020,000Dec 08 09:10 AM
Lim Jonathan EChairman & CEODec 05 '23Buy1.69721,8501,217,76112,899,360Dec 06 07:41 PM
Casdin Alexander W.DirectorDec 04 '23Buy1.6630,00049,785493,974Dec 04 06:23 PM
Lim Jonathan EChairman & CEOOct 05 '23Buy2.031,000,0002,026,00019,456,216Oct 10 08:00 AM
SXTC - China SXT Pharmaceuticals Inc - Stock Price Chart
TickerSXTC [NASD]
CompanyChina SXT Pharmaceuticals Inc
CountryChina
IndustryDrug Manufacturers - Specialty & Generic
Market Cap0.66MEPS (ttm)-1.16
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.39EPS next 5Y-
P/B4.12EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own3.13%Inst Own0.51%
Insider Trans0.00%Inst Trans297.32%
Short Float2.61%Earnings-
Analyst Recom-Target Price-
Avg Volume956.20K52W Range0.94 - 9.38
Oct-26-23 04:05PM China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq's Minimum Bid Price Rule (GlobeNewswire)
Oct-04-23 08:30AM China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split (GlobeNewswire)
Aug-02-23 06:03AM China SXT Pharmaceuticals Full Year 2023 Earnings: US$0.89 loss per share (vs US$5.52 loss in FY 2022) (Simply Wall St.)
May-10-23 08:00AM China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule (GlobeNewswire) +6.05%
Mar-29-23 09:43AM Insiders who placed huge bets on China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) earlier this year would be disappointed with the 12% drop (Simply Wall St.)
Nov-07-22 08:00AM China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency (GlobeNewswire)
May-18-22 12:30PM China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split (GlobeNewswire) -27.93%
Mar-14-22 10:33PM China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million (GlobeNewswire) -9.81%
Jan-20-22 12:30PM Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC). (ACCESSWIRE)
10:45AM China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment (GlobeNewswire)
China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). Its product categories include directly-oral, after-soaking-oral, fine, and regular TCMP. The firm distributes its product under the Suxuantang brand. The company was founded by Feng Zhou in 2005 and is headquartered in Taizhou, China.
CCJ - Cameco Corp. - Stock Price Chart
TickerCCJ [NYSE]
CompanyCameco Corp.
CountryCanada
IndustryUranium
Market Cap23.03BEPS (ttm)0.40
P/E132.43EPS this Y48.42%
Forward P/E40.46EPS next Y52.48%
PEG2.74EPS past 5Y13.73%
P/S12.27EPS next 5Y48.31%
P/B5.10EPS Q/Q-105.93%
Dividend0.15%Sales Q/Q-7.51%
Insider Own0.35%Inst Own77.30%
Insider Trans0.00%Inst Trans-0.83%
Short Float4.33%EarningsApr 30/b
Analyst Recom1.36Target Price55.43
Avg Volume4.48M52W Range26.15 - 53.17
Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.
CANF - Can-Fite Biopharma Ltd ADR - Stock Price Chart
TickerCANF [AMEX]
CompanyCan-Fite Biopharma Ltd ADR
CountryIsrael
IndustryBiotechnology
Market Cap11.88MEPS (ttm)-1.86
P/E-EPS this Y51.05%
Forward P/E-EPS next Y24.49%
PEG-EPS past 5Y48.75%
P/S16.05EPS next 5Y-
P/B1.73EPS Q/Q67.30%
Dividend-Sales Q/Q-21.32%
Insider Own-Inst Own9.57%
Insider Trans-Inst Trans-
Short Float0.22%EarningsMar 28/b
Analyst Recom1.00Target Price15.00
Avg Volume19.95K52W Range1.81 - 3.33
May-13-24 07:00AM Can-Fite: 75 Oncologists and Coordinators from Europe US and Israel Participated in a Conference Aimed at Accelerating Patient Enrolment for the Pivotal Phase 3 Advanced Liver Cancer Study (Business Wire)
May-10-24 09:00AM Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE)
06:23AM Can-Fite receives FDA IND clearance for Phase IIb MASH treatment trial (Clinical Trials Arena)
May-09-24 07:00AM Can-Fite: FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study (Business Wire) +6.03%
May-06-24 07:00AM Can-Fite Received Notice of Allowance from the European Patent Office for the Treatment of Erectile Dysfunction with CF602 (Business Wire)
Apr-29-24 09:00AM Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-25-24 07:00AM Long-term Complete Response to Can-Fite's Namodenoson in Patient with Advanced Liver Cancer: Article Published in a Leading Scientific Journal (Business Wire)
Apr-15-24 07:00AM Can-Fite: Scientific Article Published by KOL Presents Namodenoson as a Promising Drug Candidate to Treat Advanced Liver Cancer and MASH (Business Wire)
Apr-03-24 07:00AM Can-Fite: Submits FDA with an IND Application to Conduct Phase IIb Clinical Trial of Namodenoson in MASH Patients (Business Wire)
Apr-01-24 07:00AM Can-Fite BioPharma, Ltd. to Present at the LD Micro Invitational XIV (Newsfile)
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.
SLI - Standard Lithium Ltd - Stock Price Chart
TickerSLI [AMEX]
CompanyStandard Lithium Ltd
CountryCanada
IndustryOther Industrial Metals & Mining
Market Cap326.60MEPS (ttm)-0.24
P/E-EPS this Y11.38%
Forward P/E-EPS next Y28.89%
PEG-EPS past 5Y-15.08%
P/S-EPS next 5Y-
P/B2.85EPS Q/Q-38.59%
Dividend-Sales Q/Q-
Insider Own7.24%Inst Own17.19%
Insider Trans0.00%Inst Trans-
Short Float3.58%EarningsMay 10/b
Analyst Recom1.00Target Price4.17
Avg Volume1.23M52W Range1.05 - 4.85
Standard Lithium Ltd. engages in the testing and proving of the commercial viability of lithium extraction. Its projects include Arkansas Lithium, Lithium Brine Processing, and California Lithium. The company was founded by Alvaro Anthony on August 14, 1998 and is headquartered in Vancouver, Canada.
FTK - Flotek Industries Inc - Stock Price Chart
TickerFTK [NYSE]
CompanyFlotek Industries Inc
CountryUSA
IndustryOil & Gas Equipment & Services
Market Cap114.19MEPS (ttm)0.05
P/E77.31EPS this Y-17.33%
Forward P/E11.32EPS next Y34.21%
PEG7.73EPS past 5Y57.18%
P/S0.63EPS next 5Y10.00%
P/B1.10EPS Q/Q142.74%
Dividend-Sales Q/Q-15.90%
Insider Own3.71%Inst Own11.66%
Insider Trans7.90%Inst Trans-0.69%
Short Float1.54%EarningsMay 07/a
Analyst Recom1.00Target Price6.50
Avg Volume53.16K52W Range2.64 - 5.70
Flotek Industries, Inc. engages in the business of creating unique solutions to reduce the environmental impact of energy on air, water, land, and people. It operates through the following segments: Chemistry Technologies (CT), Data Analytics (DA), and Corporate and Other. The CT segment includes developing, manufacturing, packaging, distributing, delivering, and marketing green specialty chemicals that help customers meet their environmental, social, and governance and operational goals and aims to enhance the profitability of hydrocarbon producers. The DA segment focuses on enabling users to maximize the value of their hydrocarbon associated processes by providing real-time data and analytics associated with the streams in seconds rather than minutes or days. The company was founded on May 17, 1985 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nierenberg DavidDirectorDec 14 '23Buy3.7219,48172,469765,150Dec 15 09:31 AM
Nierenberg DavidDirectorDec 13 '23Buy3.5333,118116,907753,202Dec 13 04:29 PM
Nierenberg DavidDirectorDec 12 '23Buy3.4212,73543,554732,892Dec 13 04:29 PM
Nierenberg DavidDirectorDec 11 '23Buy3.199,00628,729411,305Dec 13 04:29 PM
Ezell Ryan GillisCEONov 27 '23Buy4.006,22524,87090,803Nov 27 04:28 PM
EU - enCore Energy Corp - Stock Price Chart
TickerEU [NASD, RUT]
CompanyenCore Energy Corp
CountryUSA
IndustryUranium
Market Cap854.13MEPS (ttm)-0.12
P/E-EPS this Y98.38%
Forward P/E16.20EPS next Y11320.77%
PEG-EPS past 5Y-124.91%
P/S28.11EPS next 5Y-
P/B2.43EPS Q/Q48.64%
Dividend-Sales Q/Q-
Insider Own1.98%Inst Own33.45%
Insider Trans0.00%Inst Trans-
Short Float2.27%EarningsMay 10/a
Analyst Recom1.00Target Price6.44
Avg Volume1.16M52W Range1.93 - 5.05
enCore Energy Corp. engages in the acquisition and exploration of resource properties. Its projects portfolio includes the Kingsville Dome, Rosita, Vasquez, Butler Ranch in Texas, Crownpoint & Hosta Butte, Nose Rock, Cebolleta, Juan Tafoya, West Largo, Ambrosia Lake-Treeline, Marquez, Checkerboard Mineral Rights in New Mexico, Moonshine Springs in Arizona, and White Canyon District in Utah. The company was founded on October 30, 2009 and is headquartered in Corpus Christi, TX.
HBM - Hudbay Minerals Inc. - Stock Price Chart
TickerHBM [NYSE]
CompanyHudbay Minerals Inc.
CountryCanada
IndustryCopper
Market Cap3.61BEPS (ttm)0.23
P/E45.26EPS this Y107.32%
Forward P/E13.10EPS next Y64.38%
PEG-EPS past 5Y-8.17%
P/S1.89EPS next 5Y-
P/B1.71EPS Q/Q206.25%
Dividend0.14%Sales Q/Q78.83%
Insider Own0.23%Inst Own63.31%
Insider Trans0.00%Inst Trans1.61%
Short Float1.62%EarningsMay 14/b
Analyst Recom1.27Target Price10.78
Avg Volume2.91M52W Range3.94 - 10.28
Hudbay Minerals, Inc. operates as a mining company. The firm engages in the production of copper concentrate, molybdenum concentrate and zinc metal. It focuses on the discovery, production and marketing of base and precious metals. The company was founded on January 16, 1996 and is headquartered in Toronto, Canada.
UEC - Uranium Energy Corp - Stock Price Chart
TickerUEC [AMEX, RUT]
CompanyUranium Energy Corp
CountryUSA
IndustryUranium
Market Cap3.00BEPS (ttm)-0.01
P/E-EPS this Y318.80%
Forward P/E51.52EPS next Y558.25%
PEG-EPS past 5Y39.63%
P/S50.49EPS next 5Y-
P/B3.87EPS Q/Q-80.56%
Dividend-Sales Q/Q-99.76%
Insider Own1.78%Inst Own67.77%
Insider Trans-1.51%Inst Trans6.48%
Short Float9.76%EarningsMar 11/b
Analyst Recom1.00Target Price10.36
Avg Volume6.71M52W Range2.45 - 8.34
Uranium Energy Corp. engages in uranium and titanium mining and related activities, including exploration, pre-extraction, extraction, and processing of uranium concentrates, and titanium minerals. It operates through the following geographical segments: United States, Canada, and Paraguay. The company was founded by Alan P. Lindsay and Amir Adnani on May 16, 2003 and is headquartered in Corpus Christi, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KONG DAVIDDirectorMar 12 '24Option Exercise0.9450,00047,105197,835Mar 14 05:02 PM
KONG DAVIDDirectorMar 12 '24Sale6.8126,000177,073154,085Mar 14 05:02 PM
DELLA VOLPE VINCENTDirectorFeb 01 '24Sale8.1784,000685,983186,095Feb 05 05:44 PM
OBARA PATChief Financial OfficerNov 16 '23Sale6.074,87729,620788,000Nov 16 06:34 PM
OBARA PATChief Financial OfficerNov 14 '23Option Exercise0.94150,000141,315887,755Nov 16 06:34 PM
SSRM - SSR Mining Inc - Stock Price Chart
TickerSSRM [NASD]
CompanySSR Mining Inc
CountryUSA
IndustryGold
Market Cap1.16BEPS (ttm)-2.09
P/E-EPS this Y-92.90%
Forward P/E20.21EPS next Y210.73%
PEG-EPS past 5Y-
P/S0.87EPS next 5Y-
P/B0.38EPS Q/Q-1103.32%
Dividend1.90%Sales Q/Q-26.82%
Insider Own1.10%Inst Own67.10%
Insider Trans-0.09%Inst Trans0.06%
Short Float2.67%EarningsMay 08/a
Analyst Recom3.11Target Price5.31
Avg Volume4.12M52W Range3.76 - 16.40
SSR Mining, Inc. is a gold company, which engages in the operation, development, exploration, and acquisition of metal resource properties. It operates through the following business segments: Copler, Marigold, Seabee, Puna and the Exploration, Evaluation, and Development Properties. The Copler, Marigold, Seabee, and Puna segment represent its four operating mine sites. The Exploration, Evaluation, and Development Properties segment includes a portfolio of prospective exploration tenures. The company was founded on December 11, 1946 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ebbett JohnEVP, Growth and InnovationMar 07 '24Sale4.522,0769,38430,205Mar 11 04:46 PM
1910111213141516171819